Founded in 2013, VESALIO™ is a privately held medical device company focused on advancing technology needed to improve outcomes in stroke treatment.
The Company’s proprietary NeVa™ platform is designed to achieve superior, safe and repeatable clinical outcomes by providing physicians first pass success in effectively removing the entire spectrum of clot from neurovascular anatomy.
Ischemic Stroke is a devastating acute condition where the patient risks losing his life or neurological function. An emergency condition, where death spreads through brain tissue like wildfire, and where every minute is crucial.
Today, thanks to highly trained neuro-endovascular interventionalists, saving patients once considered untreatable is possible. Stroke teams race against time to bring the patient to the cath lab without wasting any time and pressure is on during the procedure as access is gained to the occluded arteries and neurothrombectomy devices are deployed in order to order to capture and remove the clots that block circulation to precious neurons.
Current stent retrievers have crossed the chasm into mainstream therapeutic use, launching a new standard of care. However, today's most commonly employed devices were adapted from technologies used for other indications, and are not specifically optimized for removing all neurovascular clots.
Clots come in different sizes and consistency. Studies have shown that when it comes to the more organized, fibrin-rich, hard or calcified varieties, conventional neuro-thrombectomy devices require multiple passes or fail completely.
NeVa™ is designed 1st Pass Success with ALL clot types taking clot capture to the next level with Drop Zone™ Technology.